These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2064960)

  • 1. Establishment and characterization of a plasma cell leukaemia cell line dependent for growth on IL-6 and a bi-phenotypic subclone dependent upon both IL-3 and IL-6.
    Kobayashi M; Miyagishima T; Imamura M; Maeda S; Gotohda Y; Iwasaki H; Sakurada K; Miyazaki T
    Br J Haematol; 1991 Jun; 78(2):217-21. PubMed ID: 2064960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-proliferative effect of IFN-gamma in immune regulation. II. IFN-gamma inhibits the proliferation of murine bone marrow cells stimulated with IL-3, IL-4, or granulocyte-macrophage colony-stimulating factor.
    Gajewski TF; Goldwasser E; Fitch FW
    J Immunol; 1988 Oct; 141(8):2635-42. PubMed ID: 2971726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cellular and biological characterization of CD7-positive acute leukemia cells--an investigation of the established cell line, HSM911].
    Iwasaki H
    Hokkaido Igaku Zasshi; 1994 Jul; 69(4):750-66. PubMed ID: 7525434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of interleukin 6 on in vitro human megakaryocytopoiesis: its interaction with other cytokines.
    Bruno E; Hoffman R
    Exp Hematol; 1989 Nov; 17(10):1038-43. PubMed ID: 2680567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW; Li F; Pettit GR; Grant S
    Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of recombinant and purified hematopoietic growth factors on human megakaryocyte colony formation.
    Bruno E; Briddell R; Hoffman R
    Exp Hematol; 1988 Jun; 16(5):371-7. PubMed ID: 2453373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of BCL-1 murine B-cell leukemia with recombinant cytokines. Comparative analysis of the anti-leukemic potential of interleukin 1 beta (IL-1 beta), interleukin 2 (IL-2), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF alpha), granulocyte colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), and their combination.
    Chelstrom LM; Finnegan D; Uckun FM
    Leuk Lymphoma; 1992 May; 7(1-2):79-86. PubMed ID: 1282065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
    Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
    Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of recombinant interleukin 4 on the growth and differentiation of blast progenitors stimulated with G-CSF, GM-CSF and IL-3 from acute myeloblastic leukaemia patients.
    Imai Y; Tohda S; Nagata K; Suzuki T; Nara N; Aoki N
    Br J Haematol; 1991 Jun; 78(2):173-9. PubMed ID: 1712223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of interleukin-6 and granulocyte colony-stimulating factor on the proliferation of leukemic blast progenitors from acute myeloblastic leukemia patients.
    Suzuki T; Morio T; Tohda S; Nagata K; Yamashita Y; Imai Y; Aoki N; Hirashima K; Nara N
    Jpn J Cancer Res; 1990 Oct; 81(10):979-86. PubMed ID: 1699919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow.
    Gazzola MV; Collins NH; Tafuri A; Keever CA
    Exp Hematol; 1992 Feb; 20(2):201-8. PubMed ID: 1371965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiation in DNA synthesis by colony-stimulating factors in subsets of human CD34+ marrow cells.
    Strauss LC; Welsh SB; Civin CI
    Exp Hematol; 1991 Sep; 19(8):734-41. PubMed ID: 1714400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 (B-cell stimulatory factor 2)-dependent growth of a Lennert's lymphoma-derived T-cell line (KT-3).
    Shimizu S; Hirano T; Yoshioka R; Sugai S; Matsuda T; Taga T; Kishimoto T; Konda S
    Blood; 1988 Nov; 72(5):1826-8. PubMed ID: 3052631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 reduces the optimal growth in vitro of leukemic blast progenitors from acute myeloblastic leukemia patients.
    Suzuki T; Bessho M; Hirashma K; Tohda S; Nagata K; Imai Y; Nara N
    Acta Haematol; 1992; 87(1-2):63-8. PubMed ID: 1374992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of recombinant hemopoietic growth factors on human megakaryocyte colony formation in serum-free cultures.
    Teramura M; Katahira J; Hoshino S; Motoji T; Oshimi K; Mizoguchi H
    Exp Hematol; 1989 Nov; 17(10):1011-6. PubMed ID: 2680566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro effects of recombinant interleukin 7 on growth and differentiation of bone marrow pro-B- and pro-T-lymphocyte clones and fetal thymocyte clones.
    Takeda S; Gillis S; Palacios R
    Proc Natl Acad Sci U S A; 1989 Mar; 86(5):1634-8. PubMed ID: 2784210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between purified murine colony-stimulating factors (natural CSF-1, recombinant GM-CSF, and recombinant IL-3) on the in vitro proliferation of purified murine granulocyte-macrophage progenitor cells.
    Williams DE; Straneva JE; Cooper S; Shadduck RK; Waheed A; Gillis S; Urdal D; Broxmeyer HE
    Exp Hematol; 1987 Nov; 15(10):1007-12. PubMed ID: 3311784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival.
    Komatsu N; Nakauchi H; Miwa A; Ishihara T; Eguchi M; Moroi M; Okada M; Sato Y; Wada H; Yawata Y
    Cancer Res; 1991 Jan; 51(1):341-8. PubMed ID: 1824823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 inhibits the chemotaxis of human malignant plasma cell lines.
    Shibayama H; Tagawa S; Hattori H; Harigaya K; Taga T; Machii T; Kitani T
    Br J Haematol; 1996 Jun; 93(3):534-41. PubMed ID: 8652370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.